Viatris
Gerrard Terlouw is a highly experienced professional in the pharmaceutical and biotechnology sectors, currently serving as the VP Head of Business Development Europe, Emerging Markets and JANZ at Viatris since January 2024. Additionally, Gerrard holds a position on the Board of Directors at Berlin Cures Holding AG. With a career spanning over two decades at Novartis, Gerrard has contributed significantly in various roles, including Global Head of Business Development & Licensing in Immunology & Dermatology, where Gerrard developed comprehensive licensing strategies and secured a robust deal pipeline. Gerrard's earlier positions at Novartis also include leadership in negotiations for integrated hospital care and project management in transplantation and oncology. Gerrard's educational background includes advanced degrees in Toxicology, Pharmacy, and Business Management from prestigious institutions such as ETH Zürich, Utrecht University, and Harvard Business School.
This person is not in any teams
This person is not in any offices
Viatris
42 followers
Viatris is a new kind of global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including a global workforce of approximately ~45,000, Viatris aims to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.